Collaborative, team-based care models for improved patient care can bridge the gap between doctors and pharmacists. But just because it makes sense doesn’t always make it so.
The decision comes after the FTC's warnings to drugmakers over the misuse of Orange Book patent listings to wrongly extend patent monopolies on brand-name drugs, per a Reuters report.